Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Test Type
1.2.3. End-use
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Outlook
2.2.2. Test Type Outlook
2.2.3. End-use Outlook
2.3. Competitive Insights
Chapter 3. U.S. Autoimmune Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Presence of Research Funding Programs
3.2.1.2. Presence of Favorable Government Initiatives
3.2.1.3. Growing Patient Awareness Levels
3.2.1.4. Technological Innovation in the Form of Lab Automation
3.2.2. Market Restraint Analysis
3.2.2.1. Slow Diagnostic Result Turnaround Times and Lack of Skilled
3.3. U.S. Autoimmune Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. Autoimmune Disease Diagnostics Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Autoimmune Disease Diagnostics Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. U.S. Autoimmune Disease Diagnostics
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.2. Rheumatoid Arthritis
4.4.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.3. Ankylosing Spondylitis Diagnostics
4.4.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.4. Systemic Lupus Erythematosus (SLE)
4.4.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Localized Autoimmune Disease Diagnostics
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.2. Multiple Sclerosis
4.4.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.3. Type 1 Diabetes
4.4.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.4. Hashimoto's Thyroiditis
4.4.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.5. Idiopathic Thrombocytopenic Purpura
4.4.2.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.6. Others
4.4.2.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Autoimmune Disease Diagnostics Market: Test Type Estimates & Trend Analysis
5.1. Test Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Autoimmune Disease Diagnostics Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Antinuclear Antibody Tests
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Autoantibody Tests
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. C-reactive Protein (CRP)
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.4. Complete Blood Count (CBC)
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.5. Urinalysis
5.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Autoimmune Disease Diagnostics Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Autoimmune Disease Diagnostics Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Hospitals
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Diagnostic Centers
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Autoimmune Disease Diagnostics Market: Region Estimates & Trend Analysis
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Autoimmune Disease Diagnostics Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. Midwest
7.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of Key Distributors and Channel Partners
8.3.2. Key Customers
8.3.3. Key Company Heat Map Analysis, 2023
8.4. Company Profiles
8.4.1. Medtronic
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Boston Scientific Corporation
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. AngioDynamics
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bioventus Inc. (Misonix Inc.)
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. EDAP TMS
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Chongqing Haifu Medical Technology Co., Ltd
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Mermaid Medical
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. HealthTronics, Inc.
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. H.S. Hospital Service S.p.A.
8.4.10.1. Company Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 3 U.S. Autoimmune Disease Diagnostics Market, by Test Type, 2018-2030 (USD Million)
Table 4 U.S. Systemic Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 5 U.S. Localized Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 6 U.S. Autoimmune Disease Diagnostics Market, by End-use, 2018-2030 (USD Million)
Table 7 U.S. Autoimmune Disease Diagnostics Market, by Region, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. Autoimmune Disease Diagnostics Market: Market Outlook
Figure 9 U.S. Autoimmune Disease Diagnostics Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 U.S. Autoimmune Disease Diagnostics Market Driver Impact
Figure 14 U.S. Autoimmune Disease Diagnostics Market Restraint Impact
Figure 15 U.S. Autoimmune Disease Diagnostics Market: Type Movement Analysis
Figure 16 U.S. Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
Figure 17 Systemic Autoimmune Disease Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Rheumatoid Arthritis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 Ankylosing Spondylitis Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 20 Systemic Lupus Erythematosus (SLE) Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 21 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Localized Autoimmune Disease Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Multiple Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Type 1 Diabetes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Hashimoto's Thyroiditis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Idiopathic Thrombocytopenic Purpura Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 U.S. Autoimmune Disease Diagnostics Market: Treatment Movement Analysis
Figure 29 U.S. Autoimmune Disease Diagnostics Market: Treatment Outlook and Key Takeaways
Figure 30 Surgical Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 Percutaneous Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Laparoscopic Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 U.S. Autoimmune Disease Diagnostics Market: Application Movement Analysis
Figure 34 U.S. Autoimmune Disease Diagnostics Market: Application Outlook and Key Takeaways
Figure 35 Kidney Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Liver Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Breast Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Lung Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Prostate Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Other Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 U.S. Autoimmune Disease Diagnostics Market: Regional Movement Analysis
Figure 42 U.S. Autoimmune Disease Diagnostics Market: Regional Outlook and Key Takeaways
Figure 43 West Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Midwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Northeast Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Southwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Southeast Market Estimates and Forecasts, 2018-2030 (USD Million)